Highbridge Capital Management’s Pediatrix Medical MD Stock Holding History

Highbridge Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-124,386	Closed	-$5.38M	–	726
2018 Q2	$5.38M	Sell	124,386 -4,321	-3%	-$207K	0.11%	236
2018 Q1	$7.16M	Buy	+128,707	New	+$7.06M	0.12%	225
2017 Q4	–	Sell	-10,173	Closed	-$438K	–	1831
2017 Q3	$438K	Buy	+10,173	New	+$483K	0.01%	1007
2014 Q4	–	Sell	-29,310	Closed	-$1.61M	–	1324
2014 Q3	$1.61M	Buy	+29,310	New	+$1.66M	0.02%	535

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Highbridge Capital Management's MD Position: Q3 2018 in Review

Highbridge Capital Management sold out of Pediatrix Medical (MD) in Q3 2018, closing a stake of 124,386 shares — an estimated $5.38M sold.

Highbridge Capital Management first reported a position in MD in Q3 2014 and held it in 4 quarters. The position peaked at $7.16M in Q1 2018. 320 funds tracked by Wall St. Rank hold MD as of Q3 2018.

Highbridge Capital Management reported no remaining Pediatrix Medical position as of Q3 2018 after selling out during the quarter.
Highbridge Capital Management sold 124,386 Pediatrix Medical shares in Q3 2018, an estimated $5.38M.
Highbridge Capital Management first reported a position in Pediatrix Medical in Q3 2014 and held it in 4 quarters.
Highbridge Capital Management's Pediatrix Medical position peaked at $7.16M in Q1 2018.
320 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.